Ionis Pharmaceuticals IONS Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, basic (in shares) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's weighted average common shares outstanding, basic (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's weighted average common shares outstanding, basic (in shares)?
- Ionis Pharmaceuticals (IONS) reported weighted average common shares outstanding, basic (in shares) of $164.87M in Q1 2026.
- How has Ionis Pharmaceuticals's weighted average common shares outstanding, basic (in shares) changed year-over-year?
- Ionis Pharmaceuticals's weighted average common shares outstanding, basic (in shares) increased by 3.9% year-over-year, from $158.74M to $164.87M.
- What is the long-term trend for Ionis Pharmaceuticals's weighted average common shares outstanding, basic (in shares)?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's weighted average common shares outstanding, basic (in shares) has grown at a 3.1% compound annual growth rate (CAGR), from $564.08M to $637.65M.
- What does weighted average common shares outstanding, basic (in shares) mean?
- The average number of common shares that were issued and outstanding during the reporting period. This metric is the denominator used to calculate basic earnings per share.